Cicalux

01 / WHAT IT BUILT

What the company did

CicaLux Inc. is the US subsidiary (Chula Vista, California) of Belgian medtech company Alvalux Medical. It sells an award-winning wearable scar-care device — CicaLux Energized Scar-Care — that combines hydration, heat and compression ('Triple Action Therapy') with phototherapy (red/blue light) to improve healing of old and new hypertrophic and keloid scars after surgeries such as C-sections, hysterectomies, tummy tucks and breast augmentation. CE-marked and FDA-registered, and patented in the US (U.S. Patent 10,953,238, March 2021), the $89 device is sold online and through retailers in the US, EU, UK, Switzerland, Australia and other markets. The company appears to be active with its product in market — no shutdown, bankruptcy or failure was found in any source, so this record appears to be a misclassification.

03 / EVENT HISTORY

Events in the structured record

1. 2020
   Founded and launched

   CicaLux Inc. founded in Chula Vista, California as the US subsidiary of Belgium's Alvalux Medical; the CicaLux Energized Scar-Care wearable was already winning awards (Gold at Mom's Choice Awards USA, Top Innovation at Victoires de la Beauté France 2019–20) and launched in the UK.

2. 2021
   US patent

   Awarded its first US patent (U.S. Patent 10,953,238) for the wearable dermal-repair system; device CE-marked and FDA-registered, MSRP $89 per 60-day kit, sold via cicalux.us, Amazon, Walmart.com and other retailers.

3. 2022
   CES and expansion

   Showcased at CES 2022 (Eureka Park) as part of the Wallonia delegation; device available in the US, EU, UK, Switzerland, Australia, Hong Kong, Egypt, Colombia and India. No shutdown or failure found — the company appears active and the record appears misclassified.